Translate Bio, Inc. (TBIO) Prices 9.35M Share IPO at $13/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Translate Bio (TBIO) IPO Opens 12% Lower
June 28, 2018 12:08 PM EDTToday's IPO for Translate Bio (NASDAQ: TBIO) opened for trading at $11.50 after pricing 9,350,000 shares of its common stock at a price to the public of $13.00 per share.
In addition, Translate Bio has granted the underwriters a 30-day option to purchase up to 1,402,500... More
